WHO Definition (2021): Long COVID occurs in individuals with a history of probable or confirmed SARS-CoV-2 infection, with symptoms beginning within 3 months of acute illness, lasting at least 2 months, and not explained by an alternative diagnosis. Symptoms typically develop ≥4 weeks after initial infection.
Vaccination reduces long COVID risk by approximately 50% in those who experience breakthrough infection.
Post-viral fatigue is the most consistently reported symptom — characterised by exhaustion disproportionate to activity, not relieved by rest, and worsened by exertion (post-exertional malaise).
Signs/symptoms of COVID-19 lasting up to 4 weeks.
Signs/symptoms from 4 to 12 weeks post-infection.
Signs/symptoms persisting beyond 12 weeks that are not explained by an alternative diagnosis. Symptoms may be continuous or fluctuating/relapsing.
Red Flags Requiring Urgent Investigation:
New significant breathlessness | Chest pain | Palpitations with syncope | Unexplained weight loss | Haemoptysis | Unilateral leg swelling (DVT/PE) | Cognitive decline progressive beyond fatigue | High fever
| Feature | Post-COVID ICU Syndrome | Community Long COVID |
|---|---|---|
| Onset | After ICU/hospital admission | After mild/moderate COVID |
| Key features | Muscle wasting, PTSD, cognitive impairment, deconditioning | Fatigue, brain fog, breathlessness, palpitations |
| PTSD | Common — flashbacks, nightmares, hypervigilance | Less common — anxiety/depression predominate |
| Rehabilitation | Structured inpatient/outpatient MDT | Community MDT / long COVID clinic |
| Prognosis | Significant functional impairment possible | Variable; majority improve within 12 months |
The Gulf region experienced significant COVID case burden 2020–2022. Saudi Arabia, UAE, Kuwait, Qatar, Bahrain and Oman all reported substantial waves, with healthcare systems under significant pressure.
Large numbers of HCWs across GCC were infected, many developing long COVID. This created significant workforce implications — reduced capacity, sick leave, early retirement of experienced nurses and physicians.
Most common respiratory symptom. Multifactorial — breathing pattern disorder, deconditioning, cardiac, or true fibrosis. Careful assessment essential before attributing to single cause.
Occurs in a minority — particularly post-severe/ICU COVID. Progressive fibrotic changes on HRCT. Antifibrotic therapy considered in progressive cases.
May persist post-acute phase. Exudative or transudative. Requires investigation to exclude other causes (malignancy, TB — relevant in GCC).
Persistent GGOs after acute COVID suggest ongoing inflammation or early fibrosis. Common in post-hospitalised patients. May resolve over 3–6 months in milder cases. Follow-up HRCT at 3 months recommended.
Traction bronchiectasis, honeycombing, and reticulation indicate fibrosis. Associated with reduced DLCO. Refer to respiratory medicine. Post-COVID ILD management follows standard ILD guidelines — consider antifibrotics if progressive.
Microthrombi and endothelial damage in pulmonary microvasculature contribute to breathlessness without parenchymal changes. Normal spirometry but reduced DLCO. CTPA may be normal — consider SPECT-V/Q or CPET.
Important: Breathing pattern disorder (BPD) / dysfunctional breathing is common post-COVID and frequently misattributed to fibrosis or cardiac disease. Characterised by overbreathing, irregular respiratory pattern, upper chest breathing, and hyperventilation symptoms.
Physiotherapy-led breathing retraining — Buteyko technique, diaphragmatic breathing, paced breathing. Address anxiety component. CBT-based respiratory physiotherapy programmes show good evidence.
6–12 week supervised programme. Evidence base growing for post-COVID breathlessness. Components: supervised exercise, education, breathwork, psychosocial support.
Key distinction: PR with graded exercise is appropriate for post-COVID deconditioning, but NOT for patients with post-exertional malaise (PEM) — see Tab 3. Careful screening required before referral.
Useful to assess functional capacity and oxygen requirements. Monitor SpO2 throughout. Desaturation <94% on exertion indicates need for ambulatory oxygen assessment.
| Cause | Clinical Clues | Key Investigation | Management |
|---|---|---|---|
| Cardiac | Exertional, orthopnoea, oedema, palpitations | Echo, BNP, ECG, Holter | Cardiology referral |
| Pulmonary (Fibrosis/ILD) | Persistent, progressive, fine crackles, reduced DLCO | HRCT, PFTs, DLCO | Respiratory physician, antifibrotics |
| Deconditioning | After prolonged bed rest/ICU, improves with exercise | CPET, 6MWT | Graded exercise (PR) |
| BPD / Anxiety | Variable, worse with stress, normal SpO2, normal imaging | Clinical assessment, Nijmegen score | Breathing retraining, CBT |
| Pulmonary Vascular | Exertional, normal spirometry, low DLCO, right heart signs | V/Q scan, CTPA, RHC | PAH specialist |
Brain Fog is a lay term describing cognitive dysfunction post-COVID. Features include difficulty concentrating, short-term memory impairment, executive function difficulties, word-finding difficulties (dysnomia), slow processing speed, and mental fatigue disproportionate to effort.
PEM is the hallmark of ME/CFS overlap in long COVID. Symptoms worsen significantly 12–48 hours after physical or cognitive exertion, with delayed recovery. Graded exercise therapy (GET) can cause significant harm in patients with PEM.
If PEM is present: use pacing, not graded exercise. Refer to long COVID specialist.
Pacing involves managing activity within the patient's current energy envelope — the level of activity that does not trigger PEM. The goal is stability before gradual, patient-led increase.
Teach patients to recognise their zone using a symptom diary. Activity includes cognitive effort (reading, screens, conversation) as well as physical. Begin with baseline stabilisation before any increase.
Hyperarousal-type insomnia is most common — difficulty falling asleep, frequent waking, non-restorative sleep. Also: vivid dreams, hypersomnia, circadian rhythm disruption.
PTSD affects up to 30% of COVID ICU survivors. Risk factors: prolonged ICU stay, awake proning, sedation/delirium, separation from family, perceived near-death experience.
Trauma-focused CBT and EMDR (Eye Movement Desensitisation and Reprocessing) — NICE-recommended for PTSD. Peer support from other ICU survivors.
Cognitive fatigue is real and disabling. Avoid dismissing brain fog — validate patient experience. Screen with MoCA or standardised cognitive tools.
POTS (Postural Orthostatic Tachycardia Syndrome) is a common autonomic manifestation of long COVID. HR rises ≥30 bpm on standing (≥40 bpm in those under 19) within 10 minutes, without orthostatic hypotension.
POTS is the most frequently identified cardiovascular complication of long COVID. Estimated in 20–30% of those with significant cardiovascular symptoms.
New AF in long COVID patients requires anticoagulation risk assessment (CHA2DS2-VASc) and cardiology review.
Costochondritis, intercostal muscle pain, and chest wall tenderness are the most frequent causes. Reproduced on palpation. Managed with analgesia and physiotherapy.
Less common but must be excluded in persistent chest pain. Features: sharp positional pain (pericarditis), troponin rise, ECG changes, fever.
Post-acute COVID is associated with a prothrombotic state — elevated D-dimer, fibrinogen, and platelet activation. VTE risk is elevated for up to 6 months post-acute COVID.
Emerging association with long COVID. Histamine excess symptoms: flushing, urticaria, GI cramping, anaphylactoid reactions. Management: H1/H2 antihistamines, low-histamine diet.
IBS-like syndrome (abdominal pain, bloating, altered bowel habit), gastric dysmotility, and microbiome disruption (dysbiosis) are common post-COVID. Management: dietary modification, probiotics (evidence limited), gastroenterology if persistent.
Diffuse hair shedding occurring 2–3 months post-COVID (and post any severe illness). Due to hair follicle cycle disruption from physiological stress. Self-limiting — regrowth expected within 6–9 months. Management: reassurance, adequate nutrition, exclude thyroid/iron deficiency. Dermatology referral only if persisting >12 months or patchy (suspect alopecia areata).
Persistent anosmia (loss of smell) and dysgeusia (altered taste) occur in 10–15% of long COVID patients. Most recover within 12 months. Olfactory training (repeated exposure to strong scents) has evidence for hastening recovery. ENT referral for persistent cases. Significant impact on quality of life, nutrition, and mental health.
Persistent rashes, urticaria, and COVID toe (chilblain-like acral lesions) may persist post-acute phase. MCAS-related urticaria responds to antihistamines. Reassure regarding most rashes being self-limiting.
Pulmonary assessment, HRCT review, DLCO interpretation, breathlessness pathway, pulmonary rehab referral.
Breathing retraining, pacing programme, graded exercise (deconditioning only), POTS reconditioning, post-ICU mobility rehabilitation.
ADL assessment, energy conservation, workplace assessment, return-to-work plan, cognitive load management.
CBT for anxiety/depression, CBT-I for insomnia, trauma-focused therapy (ICU PTSD), illness adjustment counselling.
Nutritional assessment, anti-inflammatory diet, supplementation guidance (Vit D, zinc, B vitamins), GI symptom dietary management.
POTS / arrhythmia management, pericarditis / myocarditis, cognitive assessment, autonomic testing.
HCW long COVID: Specific occupational health pathway. Fit-to-practice assessment before return to clinical duties. Reasonable adjustments including redeployment to lower-acuity areas.
| Supplement | Rationale | Notes |
|---|---|---|
| Vitamin D | Immune modulation, deficiency common | Check 25-OH-Vit D; supplement to >50 nmol/L |
| Zinc | Antiviral, immune function, anosmia recovery | Short course; avoid excess |
| B Vitamins (B12, B complex) | Neurological function, fatigue | Check B12 levels first |
| Omega-3 fatty acids | Anti-inflammatory | 2–4g EPA/DHA daily |
Depression and anxiety affect 30–50% of long COVID patients. Screen at every clinical contact — do not assume symptoms are purely physical.
Mental health stigma in GCC communities may prevent help-seeking. Frame psychological support as part of medical rehabilitation. Arabic-language resources and female-only group support options improve engagement.
Peer support groups show evidence for improved mental wellbeing, reduced isolation, improved self-management, and increased adherence to rehabilitation programmes.
Signpost patients to support groups at every clinical contact. Acknowledge the validity of their experience — patients with long COVID commonly report feeling dismissed or not believed.
Select all current symptoms and rate overall daily life impact. The tool will calculate domain burden scores and generate referral recommendations.
This tool is for educational and clinical support purposes only. It does not replace clinical assessment. Always apply individual clinical judgement and local protocols.
GCC Exam Focus: Long COVID features in DHA (Dubai), DOH (Abu Dhabi), SCFHS (Saudi Arabia), and QCHP (Qatar) nursing licensing examinations. Focus on WHO definition, POTS recognition, pacing vs GET distinction, and MDT management.
Exam key point: Graded Exercise Therapy (GET) is NOT appropriate for long COVID patients with post-exertional malaise (PEM). Always screen for PEM before recommending any exercise programme. Pacing is the evidence-based alternative.
| Domain | Key Symptoms | Priority Investigation | Referral |
|---|---|---|---|
| Respiratory | Breathlessness, reduced exercise tolerance, cough | Spirometry, HRCT, DLCO, 6MWT with SpO2 | Respiratory physician, Physiotherapy |
| Neurological | Brain fog, memory, headache, fatigue, PEM | MoCA cognitive screen, sleep assessment | Neurology, Neuropsychology, OT |
| Cardiovascular | Palpitations, POTS, chest pain, breathlessness | ECG, Echo, Holter, 10-min stand test | Cardiology, Autonomic specialist |
| Psychological | Depression, anxiety, PTSD, insomnia | PHQ-9, GAD-7, PCL-5, ISI | Psychology, Psychiatry |
| Musculoskeletal | Muscle weakness, joint pain, myalgia, deconditioning | Physiotherapy assessment, CPET | Physiotherapy, Rheumatology |
Urgent Investigation Required: New significant breathlessness • Chest pain • Palpitations with syncope • Unexplained weight loss • Haemoptysis • Unilateral leg swelling • Progressive cognitive decline